Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling |
Ding, Ning
(Department of Blood Purification, General Hospital of Shenyang Military Area Command)
Lu, Yanzhu (Department of Orthopedics, Southwest Hospital, Third Military Medical University (Army Medical University)) Cui, Hanmin (Department of Blood Purification, General Hospital of Shenyang Military Area Command) Ma, Qinyu (Department of Orthopedics, Southwest Hospital, Third Military Medical University (Army Medical University)) Qiu, Dongxia (Department of Blood Purification, General Hospital of Shenyang Military Area Command) Wei, Xueting (Department of Blood Purification, General Hospital of Shenyang Military Area Command) Dou, Ce (Department of Orthopedics, Southwest Hospital, Third Military Medical University (Army Medical University)) Cao, Ning (Department of Blood Purification, General Hospital of Shenyang Military Area Command) |
1 | Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nature reviews. Immunology 7, 292-304 |
2 | Wada T, Nakashima T, Hiroshi N and Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12, 17-25 DOI |
3 | Liu H, Wang K, Xia G et al (2018) Two sulfonate metabolites of physalin A in rats. Xenobiotica 48, 11-17 DOI |
4 | Hsu CC, Wu YC, Farh L et al (2012) Physalin B from Physalis angulata triggers the NOXA-related apoptosis pathway of human melanoma A375 cells. Food Chem Toxicol 50, 619-624 DOI |
5 | Vandenberghe I, Creancier L, Vispe S et al (2008) Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis. Biochem Pharmacol 76, 453-462 DOI |
6 | Chamoux E, Bisson M, Payet MD and Roux S (2010) TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligandinduced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption. J Biol Chem 285, 25354-25362 DOI |
7 | Sato K, Suematsu A, Nakashima T et al (2006) Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 12, 1410-1416 DOI |
8 | Kajiya H (2012) Calcium signaling in osteoclast differentiation and bone resorption. Adv Exp Med Biol 740, 917-932 DOI |
9 | Dou C, Zhang C, Kang F et al (2014) MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. Biochim Biophys Acta 1839, 1084-1096 DOI |
10 | Tomimori Y, Mori K, Koide M et al (2009) Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bones Miner Res 24, 1194-1205 DOI |
11 | Zheng Y, Chen J, Liu L, Liang X and Hong D (2016) In vivo pharmacokinetics of and tissue distribution study of physalin B after intravenous administration in rats by liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 30, 1278-1284 DOI |
12 | Dou C, Ding N, Xing J et al (2016) Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway. Cell Death Dis 7, e2162 DOI |
13 | Li P, Liu C, Hu M, Long M, Zhang D and Huo B (2014) Fluid flow-induced calcium response in osteoclasts: signaling pathways. Ann Biomed Eng 42, 1250-1260 DOI |
14 | Hadjidakis DJ and Androulakis II (2006) Bone remodeling. Ann New York Acad Sci 1092, 385-396 DOI |
15 | Rodan GA and Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289, 1508-1514 DOI |
16 | Bastos GN, Silveira AJ, Salgado CG, Picanco-Diniz DL and do Nascimento JL (2008) Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J Ethnopharmacol 118, 246-251 DOI |
17 | Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Nat Acad Sci U S A 95, 3597-3602 DOI |
18 | Hwang SY and Putney JW Jr (2011) Calcium signaling in osteoclasts. Biochim Biophys Acta 1813, 979-983 DOI |
19 | Soares MB, Bellintani MC, Ribeiro IM, Tomassini TC and Ribeiro dos Santos R (2003) Inhibition of macrophage activation and lipopolysaccaride-induced death by secosteroids purified from Physalis angulata L. Eur J Pharmacol 459, 107-112 DOI |
20 | Pinto LA, Meira CS, Villarreal CF et al (2016) Physalin F, a seco-steroid from Physalis angulata L., has immunosuppressive activity in peripheral blood mononuclear cells from patients with HTLV1-associated myelopathy. Biomed Pharmacother 79, 129-134 DOI |
21 | Yu Y, Sun L, Ma L, Li J, Hu L and Liu J (2010) Investigation of the immunosuppressive activity of Physalin H on T lymphocytes. Int Immunopharmacol 10, 290-297 DOI |
22 | Jacobo-Herrera NJ, Bremner P, Marquez N et al (2006) Physalins from Witheringia solanacea as modulators of the NF-kappaB cascade. J Nat Prod 69, 328-331 DOI |
23 | Sa MS, de Menezes MN, Krettli AU et al (2011) Antimalarial activity of physalins B, D, F, and G. J Nat Prod 74, 2269-2272 DOI |
24 | Yang YJ, Yi L, Wang Q, Xie BB, Dong Y and Sha CW (2017) Anti-inflammatory effects of physalin E from Physalis angulata on lipopolysaccharide-stimulated RAW 264.7 cells through inhibition of NF-kappaB pathway. Immunopharmacol Immunotoxicol 39, 74-79 DOI |
25 | Ding N, Wang Y, Dou C et al (2019) Physalin D regulates macrophage M1/M2 polarization via the STAT1/6 pathway. J Cell Physiol 234, 8788-8796 DOI |
26 | Liu Z, Guo F, Wang Y et al (2016) BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci Rep 6, 21146 DOI |
27 | Kim H, Kim T, Jeong BC et al (2013) Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metab 17, 249-260 DOI |
![]() |